PL2956120T3 - Leki o smaku anyżu - Google Patents

Leki o smaku anyżu

Info

Publication number
PL2956120T3
PL2956120T3 PL14707893T PL14707893T PL2956120T3 PL 2956120 T3 PL2956120 T3 PL 2956120T3 PL 14707893 T PL14707893 T PL 14707893T PL 14707893 T PL14707893 T PL 14707893T PL 2956120 T3 PL2956120 T3 PL 2956120T3
Authority
PL
Poland
Prior art keywords
medication
anise
anise flavored
flavored medication
flavored
Prior art date
Application number
PL14707893T
Other languages
English (en)
Inventor
Allyn Michael Kaufmann
James Carl Grimm
Chelsay Lynn Brewster
Thomas Edward Huetter
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL2956120T3 publication Critical patent/PL2956120T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173845Amine and quaternary ammonium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL14707893T 2013-02-13 2014-02-13 Leki o smaku anyżu PL2956120T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361764002P 2013-02-13 2013-02-13
EP14707893.5A EP2956120B1 (en) 2013-02-13 2014-02-13 Anise flavored medication
PCT/US2014/016238 WO2014127118A1 (en) 2013-02-13 2014-02-13 Anise flavored medication

Publications (1)

Publication Number Publication Date
PL2956120T3 true PL2956120T3 (pl) 2020-08-10

Family

ID=50193605

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14707893T PL2956120T3 (pl) 2013-02-13 2014-02-13 Leki o smaku anyżu

Country Status (11)

Country Link
US (4) US9457085B2 (pl)
EP (1) EP2956120B1 (pl)
CN (1) CN104936578A (pl)
AU (1) AU2014216275B2 (pl)
BR (1) BR112015019347B1 (pl)
CA (1) CA2899492C (pl)
ES (1) ES2795291T3 (pl)
MX (1) MX361099B (pl)
PL (1) PL2956120T3 (pl)
RU (1) RU2625550C2 (pl)
WO (1) WO2014127118A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2956120T3 (pl) 2013-02-13 2020-08-10 The Procter & Gamble Company Leki o smaku anyżu
CN105699555B (zh) * 2016-03-24 2018-09-11 中国标准化研究院 一种丙烯基乙基愈创木酚的液相色谱制备方法
US10086026B2 (en) * 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
EP3506885A1 (en) * 2016-09-01 2019-07-10 The Procter and Gamble Company Medication with improved taste and sensory experience
GR1009462B (el) * 2017-10-05 2019-02-15 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714872B2 (ja) 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
ES2140389T3 (es) 1990-03-02 2000-03-01 Partnership Of Isaac G Eliaz A Procedimiento y producto para favorecer el crecimiento del cbaello y el tratamiento de la piel.
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6599883B1 (en) 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
EP1997478B1 (en) 2001-02-15 2013-09-04 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20080300314A1 (en) 2003-11-21 2008-12-04 Givaudan Sa Cooling Compounds
DE602004026619D1 (en) 2003-11-21 2010-05-27 Givaudan Sa N-substituierte p-menthancarbonsäureamide
US20060188450A1 (en) 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
BRPI0620328A2 (pt) 2005-12-23 2011-11-08 Cadbury Adams Usa Llc composições que proporcionam uma sensação substancialmente similar à proporcionada pelo mentol
US20080014267A1 (en) * 2006-07-12 2008-01-17 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
WO2007089652A2 (en) 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US9155769B2 (en) * 2006-07-07 2015-10-13 The Procter & Gamble Co Flavor oils with reduced dimethyl sulfoxide content and use in oral compositions
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101868253A (zh) 2007-11-21 2010-10-20 宝洁公司 可用于咳嗽治疗的制剂、方法和试剂盒
PE20091084A1 (es) 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
WO2010019730A1 (en) 2008-08-15 2010-02-18 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
ES2626230T3 (es) 2008-11-20 2017-07-24 The Procter & Gamble Company Composiciones para la higiene personal que proporcionan una sensación refrescante mejorada
US8962057B2 (en) * 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
WO2010128026A2 (en) 2009-05-05 2010-11-11 Givaudan Sa Organic compounds
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
PL2956120T3 (pl) 2013-02-13 2020-08-10 The Procter & Gamble Company Leki o smaku anyżu
GB201314049D0 (en) 2013-08-06 2013-09-18 Rolls Royce Plc Bearing cage deflector

Also Published As

Publication number Publication date
US9839620B2 (en) 2017-12-12
EP2956120B1 (en) 2020-04-15
US20140228391A1 (en) 2014-08-14
CA2899492A1 (en) 2014-08-21
ES2795291T3 (es) 2020-11-23
US20180344670A1 (en) 2018-12-06
US20160361277A1 (en) 2016-12-15
WO2014127118A1 (en) 2014-08-21
CA2899492C (en) 2019-09-17
AU2014216275A1 (en) 2015-08-06
US9457085B2 (en) 2016-10-04
RU2625550C2 (ru) 2017-07-14
CN104936578A (zh) 2015-09-23
BR112015019347B1 (pt) 2022-12-20
EP2956120A1 (en) 2015-12-23
US20180064661A1 (en) 2018-03-08
AU2014216275B2 (en) 2018-03-15
US10071067B2 (en) 2018-09-11
MX2015010286A (es) 2015-10-29
RU2015128789A (ru) 2017-03-17
US10588872B2 (en) 2020-03-17
MX361099B (es) 2018-11-27
BR112015019347A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
ZA201905426B (en) Drug combinations
HRP20180684T1 (hr) Kombinacija lijekova
GB201404097D0 (en) No title
AU350549S (en) Breathalyzer
GB201404073D0 (en) No title
GB201800914D0 (en) Airway device
GB201322330D0 (en) Airway device
PL2956120T3 (pl) Leki o smaku anyżu
PL3089593T3 (pl) Zaawansowane formowanie gum do żucia
GB2519789B (en) Flavoured Insert
GB2520315B (en) Oral Syringes
ZA201500062B (en) Multimedia structure
GB201320786D0 (en) Medicament
TWM475268U (en) Candy teether
GB201319780D0 (en) Airway device
GB201319122D0 (en) Sleeping Bag
GB201316662D0 (en) Pharmaceutical Combination
GB201321201D0 (en) No title
GB201311350D0 (en) Step 2
GB201317011D0 (en) No Title
GB201310897D0 (en) Angloplasty catheter set
GB201305715D0 (en) Multimedia cot
GB201321044D0 (en) No Title
GB201312260D0 (en) No title
GB201312261D0 (en) No title